Design and Characterization of a Dual-Protein Strategy for an Early-Stage Assay of Ovarian Cancer Biomarker Lysophosphatidic Acid

The overall 5-year survival rate of ovarian cancer (OC) is generally low as the disease is often diagnosed at an advanced stage of progression. To save lives, OC must be identified in its early stages when treatment is most effective. Early-stage OC causes the upregulation of lysophosphatidic acid (...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Biosensors
المؤلفون الرئيسيون: Katharina Davoudian, Sandro Spagnolo, Navina Lotay, Monika Satkauskas, Gábor Mészáros, Tibor Hianik, Zsófia Keresztes, Gilbert Walker, Michael Thompson
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2024-06-01
الموضوعات:
lysophosphatidic acid
gelsolin
actin
ovarian cancer
antifouling linker
EMPAS
الوصول للمادة أونلاين:https://www.mdpi.com/2079-6374/14/6/287

الانترنت

https://www.mdpi.com/2079-6374/14/6/287

مواد مشابهة